Shares of Relx Plc (NYSE:RELX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight analysts that are currently covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company.
A number of equities research analysts have weighed in on RELX shares. Wall Street Zen raised Relx from a “hold” rating to a “buy” rating in a report on Saturday. Weiss Ratings upgraded Relx from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 7th. The Goldman Sachs Group assumed coverage on Relx in a research note on Wednesday, June 3rd. They issued a “buy” rating on the stock. Finally, Barclays reiterated an “overweight” rating on shares of Relx in a research report on Friday, July 24th.
Get Our Latest Research Report on RELX
Hedge Funds Weigh In On Relx
Relx Trading Down 3.1%
NYSE RELX opened at $35.50 on Monday. The company’s 50-day simple moving average is $34.56 and its 200 day simple moving average is $33.96. Relx has a twelve month low of $27.57 and a twelve month high of $48.40. The company has a debt-to-equity ratio of 5.23, a current ratio of 0.45 and a quick ratio of 0.40.
Relx Cuts Dividend
The company also recently announced a dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Friday, August 7th will be issued a $0.2785 dividend. The ex-dividend date of this dividend is Friday, August 7th. This represents a dividend yield of 157.0%.
Relx Company Profile
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.
Featured Stories
- Five stocks we like better than Relx
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
